Suerte, Baby Charlyn P.

HRN: 22-01-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/28/2024
12/04/2024
TOPICAL
Pea Sized
Q12
2nd Degree Burn
Waiting Final Action 
11/29/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/29/2024
12/06/2024
IV
300 Mg
Every 8 Hours
Burn Injury
Waiting Final Action 
11/29/2024
OXACILLIN 500MG (VIAL)
11/29/2024
12/06/2024
IV
550mg
Q6
Burns
Waiting Final Action 
12/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/02/2024
12/09/2024
IV
150mg
Q8H
Second Degree Burn
Waiting Final Action 
12/03/2024
MUPIROCIN 2%, 15G (TUBE)
12/02/2024
12/09/2024
TOPICAL
2%
TID
Second Degree Burn
Waiting Final Action 
12/04/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/04/2024
12/11/2024
TOPICAL
Topical
TID
Burn
Waiting Final Action 
12/05/2024
CEFTRIAXONE 1G (VIAL)
12/05/2024
12/11/2024
IV
1g
OD
2nd Degree Burn
Waiting Final Action 
12/08/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/08/2024
12/15/2024
TOPICAL
25 G
TID
Burn
Waiting Final Action 
12/08/2024
MUPIROCIN 2%, 15G (TUBE)
12/08/2024
12/15/2024
TOPICAL
15 G
TID
Burn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: